Development of a factorial design for a therapeutic plasmid DNA biosynthesis

Detalhes bibliográficos
Autor(a) principal: Martins, Luís Miguel Candeias
Data de Publicação: 2013
Tipo de documento: Dissertação
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.6/3206
Resumo: Therapeutic applications of plasmid DNA (pDNA) have significantly advanced during the last years. Currently, several pDNA-based drugs are already in the market, whereas several others have entered to phases 2 and 3 of clinical trials. The present and future demand for pDNA requires the development of efficient bioprocesses to produce it. Commonly, pDNA is produced by cultures of Escherichia coli. It has been previously demonstrated that specific strains of E. coli with a modified substrate transport system can be able to attain high cell densities in batch mode, due to the very low overflow metabolism displayed. However, the large amounts of oxygen demanded can lead to microaerobic conditions after some hours of cultivation, even at small-scale. Typically, the inherent problems for these cultures are the high oxygen demand and the accumulation of acetate, a metabolic by-product that is synthesized aerobically when the glucose rate exceeds limits. In recent years, various researches have been focused on the study of induction of plasmid DNA as well as strategies for fermentation using semi-defined mediums. These studies conceived relevant results that allow us to design a production platform for enhanced plasmid DNA. The main goal of this study is to optimize the yield of therapeutic plasmid DNA by culture of recent developed strain of Escherichia coli. The strategy is based on the variation of composition of the fermentation media in terms of nutrients and by a development of an experimental design directed to aromatic amino acids pathway. Monitoring through analytical methods is an advantage both in control and optimization of the intervenients in fermentation process. The change of composition and concentration of the substrates affect the growth of Escherichia coli VH33 and simultaneously, the quantity and quality of the plasmid in study. The experimental model confirms that the disturbing on the aromatic amino acid pathway influences the production plasmid DNA.
id RCAP_1377635048e64bbad1f1429d81029093
oai_identifier_str oai:ubibliorum.ubi.pt:10400.6/3206
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str
spelling Development of a factorial design for a therapeutic plasmid DNA biosynthesisBiomoléculas terapêuticas - DNA plasmídicoEscherichia coli VH33 - DNA plasmídicoTherapeutic applications of plasmid DNA (pDNA) have significantly advanced during the last years. Currently, several pDNA-based drugs are already in the market, whereas several others have entered to phases 2 and 3 of clinical trials. The present and future demand for pDNA requires the development of efficient bioprocesses to produce it. Commonly, pDNA is produced by cultures of Escherichia coli. It has been previously demonstrated that specific strains of E. coli with a modified substrate transport system can be able to attain high cell densities in batch mode, due to the very low overflow metabolism displayed. However, the large amounts of oxygen demanded can lead to microaerobic conditions after some hours of cultivation, even at small-scale. Typically, the inherent problems for these cultures are the high oxygen demand and the accumulation of acetate, a metabolic by-product that is synthesized aerobically when the glucose rate exceeds limits. In recent years, various researches have been focused on the study of induction of plasmid DNA as well as strategies for fermentation using semi-defined mediums. These studies conceived relevant results that allow us to design a production platform for enhanced plasmid DNA. The main goal of this study is to optimize the yield of therapeutic plasmid DNA by culture of recent developed strain of Escherichia coli. The strategy is based on the variation of composition of the fermentation media in terms of nutrients and by a development of an experimental design directed to aromatic amino acids pathway. Monitoring through analytical methods is an advantage both in control and optimization of the intervenients in fermentation process. The change of composition and concentration of the substrates affect the growth of Escherichia coli VH33 and simultaneously, the quantity and quality of the plasmid in study. The experimental model confirms that the disturbing on the aromatic amino acid pathway influences the production plasmid DNA.As aplicações terapêuticas de DNA plasmídico (pDNA) avançaram significativamente nos últimos anos. No mercado atual é possível verificar a existência de vários compostos terapêuticos que têm como base o pDNA, estando muitos outros a ser testados nas fases 2 e 3 de ensaios clínicos. A necessidade atual e futura de pDNA implica o desenvolvimento de bioprocessos cada vez mais eficientes para a sua produção. Geralmente o pDNA é produzido por culturas de Escherichia coli. Foi previamente demonstrado que culturas específicas de E. coli que possuam um sistema de transporte do substrato alterado, que não sobrecarregue o metabolismo, são capazes de atingir altas densidades celulares. No entanto, as grandes quantidades de oxigénio exigido podem levar a condições microaeróbicas após algumas horas de cultivo, mesmo que em pequena escala. Normalmente, os problemas inerentes a estas culturas são a elevada necessidade de oxigénio e a acumulação de acetato, um subproduto metabólico que é sintetizado aerobicamente quando a taxa de captação de glicose ultrapassa um determinado limite. Nos últimos anos, várias pesquisas têm tido como foco o estudo da indução de DNA plasmídico bem como as estratégias de fermentação utilizando meios semi-definidos. Estes estudos conceberam resultados relevantes que nos permitam projetar uma plataforma de produção de DNA plasmídico otimizada. O objetivo principal deste estudo é melhorar o rendimento de produção de DNA plasmídico com potencial terapêutico através da cultura de uma estirpe de Escherichia coli recentemente desenvolvida. A estratégia baseia-se na variação da composição dos meios de fermentação em termos de nutrientes e no desenvolvimento de um desenho experimental direcionado à via metabólica dos aminoácidos aromáticos. A monitorização através de métodos analíticos válidos constitui uma vantagem, tanto no controlo como na otimização, dos intervenientes do processo fermentativo. A alteração da composição e concentração dos substratos utilizados afeta o crescimento de Escherichia coli VH33, e em simultâneo, a quantidade e qualidade do plasmídio em estudo. O modelo experimental desenvolvido confirma que a perturbação da via metabólica dos aminoácidos aromáticos influencia a produção DNA plasmídio.Passarinha, Luís António PaulinoSousa, Fani Pereira deuBibliorumMartins, Luís Miguel Candeias2015-04-08T09:21:34Z20132013-102013-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10400.6/3206TID:201008408enginfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-01-16T11:41:38ZPortal AgregadorONG
dc.title.none.fl_str_mv Development of a factorial design for a therapeutic plasmid DNA biosynthesis
title Development of a factorial design for a therapeutic plasmid DNA biosynthesis
spellingShingle Development of a factorial design for a therapeutic plasmid DNA biosynthesis
Martins, Luís Miguel Candeias
Biomoléculas terapêuticas - DNA plasmídico
Escherichia coli VH33 - DNA plasmídico
title_short Development of a factorial design for a therapeutic plasmid DNA biosynthesis
title_full Development of a factorial design for a therapeutic plasmid DNA biosynthesis
title_fullStr Development of a factorial design for a therapeutic plasmid DNA biosynthesis
title_full_unstemmed Development of a factorial design for a therapeutic plasmid DNA biosynthesis
title_sort Development of a factorial design for a therapeutic plasmid DNA biosynthesis
author Martins, Luís Miguel Candeias
author_facet Martins, Luís Miguel Candeias
author_role author
dc.contributor.none.fl_str_mv Passarinha, Luís António Paulino
Sousa, Fani Pereira de
uBibliorum
dc.contributor.author.fl_str_mv Martins, Luís Miguel Candeias
dc.subject.por.fl_str_mv Biomoléculas terapêuticas - DNA plasmídico
Escherichia coli VH33 - DNA plasmídico
topic Biomoléculas terapêuticas - DNA plasmídico
Escherichia coli VH33 - DNA plasmídico
description Therapeutic applications of plasmid DNA (pDNA) have significantly advanced during the last years. Currently, several pDNA-based drugs are already in the market, whereas several others have entered to phases 2 and 3 of clinical trials. The present and future demand for pDNA requires the development of efficient bioprocesses to produce it. Commonly, pDNA is produced by cultures of Escherichia coli. It has been previously demonstrated that specific strains of E. coli with a modified substrate transport system can be able to attain high cell densities in batch mode, due to the very low overflow metabolism displayed. However, the large amounts of oxygen demanded can lead to microaerobic conditions after some hours of cultivation, even at small-scale. Typically, the inherent problems for these cultures are the high oxygen demand and the accumulation of acetate, a metabolic by-product that is synthesized aerobically when the glucose rate exceeds limits. In recent years, various researches have been focused on the study of induction of plasmid DNA as well as strategies for fermentation using semi-defined mediums. These studies conceived relevant results that allow us to design a production platform for enhanced plasmid DNA. The main goal of this study is to optimize the yield of therapeutic plasmid DNA by culture of recent developed strain of Escherichia coli. The strategy is based on the variation of composition of the fermentation media in terms of nutrients and by a development of an experimental design directed to aromatic amino acids pathway. Monitoring through analytical methods is an advantage both in control and optimization of the intervenients in fermentation process. The change of composition and concentration of the substrates affect the growth of Escherichia coli VH33 and simultaneously, the quantity and quality of the plasmid in study. The experimental model confirms that the disturbing on the aromatic amino acid pathway influences the production plasmid DNA.
publishDate 2013
dc.date.none.fl_str_mv 2013
2013-10
2013-01-01T00:00:00Z
2015-04-08T09:21:34Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.6/3206
TID:201008408
url http://hdl.handle.net/10400.6/3206
identifier_str_mv TID:201008408
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1777301773138001920